Assaf Bivas

KIP Medical is focused on research and development of an innovative plant-derived solution to treat patients with various pathological conditions involving dysregulation of the immune system, such as autoimmune diseases and transplanted organ rejection, increased activity of the immune system caused by inflammation and tissue damage, and more. KIP Medical is uniquely positioned to address the unmet medical needs of enhancing the control of the immune system in pathological immune disorders. Currently, we are focused specifically on developing a novel drug that promises to innovate the therapy of dry mouth syndrome and other inflammatory conditions. KIP Medical was born out of the collaboration between Hadassah Medical Center, Prof. Reuven Or, Dr. Osnat Hazan and Pollen Innovation Ltd, an Israeli-based investment firm focused on accelerating disruptive innovations and trends that enhance quality of life and contribute to a better and healthier world.

ODE PHARMA is a biotechnology company specializing in microbiome-based medicine. Our breakthrough treatments target breathing and lung disorders, harnessing the bodys natural systems to restore damaged lung cells and enhance respiratory health. Our technology revolves around the crucial role of mitochondria in maintaining overall health and the integrity of epithelial tissues. With promising results in COVID-19 and asthma patients, we are dedicated to addressing the rising global demand for effective and natural respiratory solutions.

Eco Wave Power (Nasdaq Stock Symbol: WAVE) is an advanced and innovative international wave power developer, headquartered in Israel. The company was established after a period of conceptualizing and planning for a new and competitive wave energy technology. Eco Wave Power is the only wave energy company to ever win the Frost & Sullivan Product Innovation Award. According to Frost & Sullivan, “Eco Wave Power efficiently handles the prominent challenges prevailing in the field and offers an all-round solution for effective energy harvesting. Based on the aforementioned performance drivers as measured through Frost & Sullivan independent analysis, Eco Wave Power is the recipient of the 2012 Frost & Sullivan New Product Innovation Award” The company has developed proprietary technology for extracting energy from ocean and sea waves and converting it into electricity. Such technology enables to deliver effective, sustainable, practical, feasible and affordable wave energy solutions, which are responsive to the needs of local communities, cities, and countries globally wide. Due to our awareness to the oscillating need of renewable energy sources, Eco Wave Power is currently focused on developing and commercializing its 100% owned patents, which are capable of producing large amounts of affordable, zero-emission renewable power. The Eco Wave Power wave energy converter is a simple and inexpensive technology to harvest wave energy from high and low waves. It is designed to be simple and robust while offering technical advantages over competing systems. Our system is being developed to produce electricity for cheaper price than traditional energy generation methods such as: coal, oil and gas as well as renewable energy generation methods such as wind and Solar. This will be achieved by using low cost materials, low maintenance price and periods and long life expectancies.

KIP Medical is focused on research and development of an innovative plant-derived solution to treat patients with various pathological conditions involving dysregulation of the immune system, such as autoimmune diseases and transplanted organ rejection, increased activity of the immune system caused by inflammation and tissue damage, and more. KIP Medical is uniquely positioned to address the unmet medical needs of enhancing the control of the immune system in pathological immune disorders. Currently, we are focused specifically on developing a novel drug that promises to innovate the therapy of dry mouth syndrome and other inflammatory conditions. KIP Medical was born out of the collaboration between Hadassah Medical Center, Prof. Reuven Or, Dr. Osnat Hazan and Pollen Innovation Ltd, an Israeli-based investment firm focused on accelerating disruptive innovations and trends that enhance quality of life and contribute to a better and healthier world.

ODE PHARMA is a biotechnology company specializing in microbiome-based medicine. Our breakthrough treatments target breathing and lung disorders, harnessing the bodys natural systems to restore damaged lung cells and enhance respiratory health. Our technology revolves around the crucial role of mitochondria in maintaining overall health and the integrity of epithelial tissues. With promising results in COVID-19 and asthma patients, we are dedicated to addressing the rising global demand for effective and natural respiratory solutions.

Pollen Innovation is an investment group established in 2020, with a mission to create a better world by nurturing brilliant entrepreneurs and impactful innovations, through a unique model of venture capital investments. We focus on disruptive technologies that contributes to the well-being of our environment and humanity, while cultivating a global network of investors, entrepreneurs, and experts. Inspired by nature, we aim to harness the power of a group to improve lives and reshape industries. Our Vision: At Pollen Innovation, we believe that nature holds valuable wisdom Like the vital creative force of pollen in nature, we aim to be a vital force in the business world by supporting entrepreneurs and cross-pollinating new ideas to bring them to life. We aspire to grow revolutionary ideas that have the potential to create a meaningful positive impact.

We develop and manufacture bio-based materials using Kenaf, a fast-growing and highly CO₂ absorbent plant. Our products are designed to replace polluting materials like plastics, mineral wool, and expanded polystyrene, while offering superior or equivalent performance and cost-efficiency.

Eco Wave Power (Nasdaq Stock Symbol: WAVE) is an advanced and innovative international wave power developer, headquartered in Israel. The company was established after a period of conceptualizing and planning for a new and competitive wave energy technology. Eco Wave Power is the only wave energy company to ever win the Frost & Sullivan Product Innovation Award. According to Frost & Sullivan, “Eco Wave Power efficiently handles the prominent challenges prevailing in the field and offers an all-round solution for effective energy harvesting. Based on the aforementioned performance drivers as measured through Frost & Sullivan independent analysis, Eco Wave Power is the recipient of the 2012 Frost & Sullivan New Product Innovation Award” The company has developed proprietary technology for extracting energy from ocean and sea waves and converting it into electricity. Such technology enables to deliver effective, sustainable, practical, feasible and affordable wave energy solutions, which are responsive to the needs of local communities, cities, and countries globally wide. Due to our awareness to the oscillating need of renewable energy sources, Eco Wave Power is currently focused on developing and commercializing its 100% owned patents, which are capable of producing large amounts of affordable, zero-emission renewable power. The Eco Wave Power wave energy converter is a simple and inexpensive technology to harvest wave energy from high and low waves. It is designed to be simple and robust while offering technical advantages over competing systems. Our system is being developed to produce electricity for cheaper price than traditional energy generation methods such as: coal, oil and gas as well as renewable energy generation methods such as wind and Solar. This will be achieved by using low cost materials, low maintenance price and periods and long life expectancies.